Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px

Document › Details

Biocartis Group N.V.. (1/23/19). "Press Release: Biocartis Upsizes Its Equity Placement Due to Significant Demand [NOT FOR US, AU, CA, JP, ZA, et al.]". Mechelen.

	Organisation	Biocartis Group N.V. (Euronext Brussels: BCART)
	Group	Biocartis (Group)
	Organisation 2	KBC Securities N.V.
	Group	KBC Group (Group) [since 3/05]
	Product	Idylla™ molecular diagnostics system
	Product 2	investment banking
	Index term	Biocartis–SEVERAL: investment, 201901 private placement €55.5m of 5m new shares at €11.1/share
	Person	Degrave, Renate (Biocartis 201611 Manager CorpComm + IR)

Original document
accessed by [iito] on 2018-01-23

Record changed: 2023-06-05

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Biocartis (Group)

[1] Biocartis Group N.V.. (4/11/23). "Press Release: Biocartis Appoints Roger Moody as New CEO". Mechelen....
[2] NeoGenomics, Inc.. (5/9/22). "Press Release: NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary". Ft. Myers, FL....
[3] Biocartis Group N.V.. (10/6/20). "Press Release: Biocartis Announces Market Release of SeptiCyte RAPID Test on Idylla". Mechelen....
[4] Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces 2019 Results and 2020 Outlook". Mechelen....
[5] Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aimed at Registration of Idylla MSI test in China". Mechelen....
[6] Biocartis Group N.V.. (6/1/19). "Press Release: Biocartis and Kite Sign Agreement for Development of Assays Supporting Kite's Therapies". Mechelen....
[7] Biocartis Group N.V.. (4/25/19). "Press Release: Biocartis Q1 2019 Business Update". Mechelen....
[8] Biocartis Group N.V.. (4/23/19). "Press Release: Biocartis Announces Global Collaboration with Covance". Mechelen....
[9] Biocartis Group N.V.. (12/3/18). "Press Release: Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla Oncotype DX Genomic Prostate Score Test". Redwood City, CA & Mechelen....
[10] Biocartis Group N.V.. (7/17/18). "Press Release: Biocartis Launches Innovative Idylla MSI Assay". Mechelen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]